Therefore, it is of interest to studyHIF-1α and HIF-2α expression levels in HNSCC tissues, as well as their impact on patient outcomes for gleaning tumorspecific biological information to develop novel markers and therapeutic targets. The gene discussed is EPAS1; the disease is head and neck squamous cell carcinoma.